NCT06691425View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 19, 2024

Primary Completion Date

July 31, 2030

Study Completion Date

July 31, 2030

Conditions
Non-metastasized Unresectable Pancreatic Carcinoma
Interventions
RADIATION

Stereotactic Body Radiation Therapy (SBRT)

SBRT (5 x 8 Gy)

DRUG

Chemotherapy

Standard of care: mFOLFIRINOX or gemcitabine/nab-paclitaxel

Trial Locations (9)

2300

RECRUITING

AZ Turnhout, Turnhout

2610

RECRUITING

ZAS Augustinus, Wilrijk

2650

RECRUITING

UZA, Edegem

2930

RECRUITING

AZ Klina, Brasschaat

3500

RECRUITING

Jessa ziekenhuis, Hasselt

3600

RECRUITING

ZOL, Genk

8000

RECRUITING

AZ Sint-Jan, Bruges

8500

RECRUITING

AZ Groeninge, Kortrijk

8800

RECRUITING

AZ Delta, Roeselare

Sponsors
All Listed Sponsors
collaborator

Kom Op Tegen Kanker

OTHER

collaborator

Naslund Medical AB

UNKNOWN

collaborator

Varian Medical Systems

INDUSTRY

lead

Cancer Research Antwerp

OTHER

NCT06691425 - Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter